Geovax Labs Inc (GOVX)
1.80
-0.12
(-6.25%)
USD |
NASDAQ |
Nov 04, 16:00
1.71
-0.09
(-5.00%)
After-Hours: 04:21
Geovax Labs Enterprise Value: 8.055M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 8.055M |
| November 01, 2024 | 8.687M |
| October 31, 2024 | 8.950M |
| October 30, 2024 | 9.213M |
| October 29, 2024 | 9.161M |
| October 28, 2024 | 9.055M |
| October 25, 2024 | 9.476M |
| October 24, 2024 | 9.845M |
| October 23, 2024 | 10.42M |
| October 22, 2024 | 9.424M |
| October 21, 2024 | 10.37M |
| October 18, 2024 | 9.740M |
| October 17, 2024 | 9.161M |
| October 16, 2024 | 9.634M |
| October 15, 2024 | 9.687M |
| October 14, 2024 | 9.161M |
| October 11, 2024 | 9.266M |
| October 10, 2024 | 9.266M |
| October 09, 2024 | 10.32M |
| October 08, 2024 | 9.003M |
| October 07, 2024 | 9.161M |
| October 04, 2024 | 9.476M |
| October 03, 2024 | 9.634M |
| October 02, 2024 | 9.740M |
| October 01, 2024 | 10.16M |
| Date | Value |
|---|---|
| September 30, 2024 | 11.27M |
| September 27, 2024 | 11.48M |
| September 26, 2024 | 11.58M |
| September 25, 2024 | 12.53M |
| September 24, 2024 | 13.06M |
| September 23, 2024 | 12.95M |
| September 20, 2024 | 14.11M |
| September 19, 2024 | 12.79M |
| September 18, 2024 | 12.74M |
| September 17, 2024 | 12.95M |
| September 16, 2024 | 12.85M |
| September 13, 2024 | 13.53M |
| September 12, 2024 | 15.06M |
| September 11, 2024 | 15.69M |
| September 10, 2024 | 15.85M |
| September 09, 2024 | 17.85M |
| September 06, 2024 | 16.58M |
| September 05, 2024 | 18.95M |
| September 04, 2024 | 18.79M |
| September 03, 2024 | 22.37M |
| August 30, 2024 | 22.95M |
| August 29, 2024 | 24.64M |
| August 28, 2024 | 24.90M |
| August 27, 2024 | 30.00M |
| August 26, 2024 | 33.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-20.59M
Minimum
Jul 22 2022
57.43M
Maximum
Aug 04 2022
2.971M
Average
2.265M
Median
Jun 14 2024
Enterprise Value Benchmarks
| Emergent BioSolutions Inc | 1.256B |
| Tonix Pharmaceuticals Holding Corp | 7.452M |
| Abbott Laboratories | 211.48B |
| SIGA Technologies Inc | 392.64M |
| Chimerix Inc | -59.43M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.064M |
| Revenue (Quarterly) | 0.3007M |
| Total Expenses (Quarterly) | 5.363M |
| EPS Diluted (Quarterly) | -1.99 |
| Profit Margin (Quarterly) | -1.68K% |
| Earnings Yield | -733.3% |
| Normalized Earnings Yield | -733.33 |